Targeting Candida spp. to develop antifungal agents

被引：25
作者：
Salci, Tania P. [1 ,2 ]
Negri, Melyssa [1 ]
Abadio, Ana K. R. [3 ]
Svidzinski, Terezinha I. E. [1 ]
Kioshima, Erika S. [1 ]
机构：
[1] Univ Estadual Maringa, Av Colombo 5-790 Jd Univ, BR-87020900 Maringa, Parana, Brazil
[2] Ctr Univ Integrado, Rodovia BR 158,Km 207, BR-87300970 Campo Mourao, Parana, Brazil
[3] Univ Estado Mato Grosso, Campus Nova Xavantina, BR-78690000 Nova Xavantina, Mato Grosso, Brazil
来源：
DRUG DISCOVERY TODAY | 2018年 / 23卷 / 04期
关键词：
RESPONSE REGULATOR GENE; CHITIN SYNTHASE GENE; PHOSPHOLIPASE-B GENE; MDR1 EFFLUX PUMP; REDUCED ECHINOCANDIN SUSCEPTIBILITY; MAJOR FACILITATOR SUPERFAMILY; AZOLE RESISTANCE MECHANISMS; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; FLUCONAZOLE RESISTANCE;
D O I：
10.1016/j.drudis.2018.01.003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Invasive fungal infections are a complex challenge throughout the world because of their high incidence, mainly in critically ill patients, and high mortality rates. The antifungal agents currently available are limited; thus, there is a need for the rapid development of new drugs. In silico methods are a modern strategy to explore interactions between new compounds and specific fungal targets, but they depend on precise genetic information. Here, we discuss the main Candida spp. target genes, including information about null mutants, virulence, cytolocalization, co-regulatory genes, and compounds that are related to protein expression. These data will provide a basis for the future in silico development of antifungal drugs.
引用
收藏
页码：802 / 814
页数：13
相关论文
共 50 条
  • [31] Candida Species Biofilms' Antifungal Resistance
    Silva, Sonia
    Rodrigues, Celia F.
    Araujo, Daniela
    Rodrigues, Maria Elisa
    Henriques, Mariana
    JOURNAL OF FUNGI, 2017, 3 (01)
  • [32] Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis
    Ells, Ruan
    Kock, Johan L. F.
    Van Wyk, Pieter W. J.
    Botes, Piet J.
    Pohl, Carolina H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 124 - 128
  • [33] Potential Antifungal Targets Based on Glucose Metabolism Pathways of Candida albicans
    Chen, Xueqi
    Zhang, Zewen
    Chen, Zuozhong
    Li, Yiman
    Su, Shan
    Sun, Shujuan
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [34] Opportunistic Pathogen Candida glabrata and the Mechanisms of its Resistance to Antifungal Drugs
    Berila, N.
    Subik, J.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2010, 59 (02): : 67 - 79
  • [35] Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata
    Ito, Yuya
    Miyazaki, Taiga
    Tanaka, Yutaka
    Suematsu, Takashi
    Nakayama, Hironobu
    Morita, Akihiro
    Hirayama, Tatsuro
    Tashiro, Masato
    Takazono, Takahiro
    Saijo, Tomomi
    Shimamura, Shintaro
    Yamamoto, Kazuko
    Imamura, Yoshifumi
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Kohno, Shigeru
    Mukae, Hiroshi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Targeting efflux pumps to overcome antifungal drug resistance
    Holmes, Ann R.
    Cardno, Tony S.
    Strouse, J. Jacob
    Ivnitski-Steele, Irena
    Keniya, Mikhail V.
    Lackovic, Kurt
    Monk, Brian C.
    Sklar, Larry A.
    Cannon, Richard D.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (12) : 1485 - 1501
  • [37] Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes
    Schwarzmueller, Tobias
    Ma, Biao
    Hiller, Ekkehard
    Istel, Fabian
    Tscherner, Michael
    Brunke, Sascha
    Ames, Lauren
    Firon, Arnaud
    Green, Brian
    Cabral, Vitor
    Marcet-Houben, Marina
    Jacobsen, Ilse D.
    Quintin, Jessica
    Seider, Katja
    Frohner, Ingrid
    Glaser, Walter
    Jungwirth, Helmut
    Bachellier-Bassi, Sophie
    Chauvel, Murielle
    Zeidler, Ute
    Ferrandon, Dominique
    Gabaldon, Toni
    Hube, Bernhard
    d'Enfert, Christophe
    Rupp, Steffen
    Cormack, Brendan
    Haynes, Ken
    Kuchler, Karl
    PLOS PATHOGENS, 2014, 10 (06)
  • [38] Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China
    Zhang, Hao
    Tan, Jingwen
    Kontoyiannis, Dimitrios P.
    Zhou, Yabin
    Liu, Weixia
    Zhu, Pengfei
    Shi, Xiuyan
    Wan, Zhe
    Li, Ruoyu
    Liu, Wei
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (02) : 166 - 170
  • [39] Production of antifungal compounds by Bacillus spp. isolates and its capacity for controlling citrus black spot under field conditions
    Kupper, Katia Cristina
    Moretto, Rafael Kupper
    Fujimoto, Andreia
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2019, 36 (01)
  • [40] Mechanisms of antifungal drug resistance in Candida dubliniensis
    Coleman, David C.
    Moran, Gary P.
    McManus, Brenda A.
    Sullivan, Derek J.
    FUTURE MICROBIOLOGY, 2010, 5 (06) : 935 - 949
12345